Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

SC Pharmaceuticals Inc (SCPH)

SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

SC Pharmaceuticals Inc 25 BURLINGTON MALL ROAD SUITE 203 BURLINGTON MA 01803 USA

www.scpharmaceuticals.com Employees: 136 P: 617-517-0730

Description:

scPharmaceuticals, Inc., is a biopharmaceutical company. It engaged in developing pharmaceutical products for subcutaneous delivery. The Company's pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. scPharmaceuticals, Inc., is based in BURLINGTON, United States.

Key Statistics

Overview:

Market Capitalization, $K 162,630
Enterprise Value, $K 154,810
Shares Outstanding, K 50,040
Annual Sales, $ 13,590 K
Annual Net Income, $ -54,810 K
Last Quarter Sales, $ 10,030 K
Last Quarter Net Income, $ -35,110 K
EBIT, $ -63,700 K
EBITDA, $ -63,680 K
60-Month Beta 0.14
% of Insider Shareholders 5.52%
% of Institutional Shareholders 89.52%
Float, K 47,278
% Float 94.48%
Short Volume Ratio 0.46

Growth:

1-Year Return -43.05%
3-Year Return -39.14%
5-Year Return -35.64%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 10.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/13/24
Next Earnings Date N/A
Earnings Per Share ttm -1.52
EPS Growth vs. Prev Qtr 15.91%
EPS Growth vs. Prev Year 9.76%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SCPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -244.93%
Return-on-Assets % -68.56%
Profit Margin % -403.31%
Debt/Equity 1.66
Price/Sales 11.78
Price/Cash Flow N/A
Price/Book 5.21
Book Value/Share 0.61
Interest Coverage -5.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar